Shawn Leland
Director/Board Member presso Fore Biotherapeutics, Inc.
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
Shawn M.
Leland was the founder of Elevation Oncology, Inc. (founded in 2019) where he held the title of President, Chief Executive Officer & Director from 2020 to 2023.
He is currently working as a Director at Fore Biotherapeutics, Inc. since 2023.
Previously, Dr. Leland worked as a Senior Director-Corporate Development & Strategy at Argos Therapeutics, Inc. from 2013 to 2017 and as a Vice President-Business Development at Verastem, Inc. from 2017 to 2019.
He obtained his undergraduate degree from Albany College of Pharmacy & Health Sciences.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ELEVATION ONCOLOGY, INC.
1.74% | 31/03/2023 | 846 826 ( 1.74% ) | 4 M $ | 31/03/2024 |
Posizioni attive di Shawn Leland
| Società | Posizione | Inizio |
|---|---|---|
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Director/Board Member | 01/09/2023 |
Precedenti posizioni note di Shawn Leland
| Società | Posizione | Fine |
|---|---|---|
| ELEVATION ONCOLOGY, INC. | Founder | 05/01/2023 |
| VERASTEM, INC. | Corporate Officer/Principal | 01/08/2019 |
| ARGOS THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2017 |
Formazione di Shawn Leland
| Albany College of Pharmacy & Health Sciences | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| VERASTEM, INC. | Health Technology |
| ELEVATION ONCOLOGY, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Health Technology |
- Borsa valori
- Insiders
- Shawn Leland
